West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance
Source: Streetwise Reports  (4/23/20)
Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. More >

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick
Source: Streetwise Reports  (4/1/20)
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. More >

Abbott Labs Launches Point-of-Care Diagnostic Tool that Can Detect COVID-19 in 5 Minutes
Source: Streetwise Reports  (3/30/20)
Shares of Abbott Laboratories opened 11% higher after the company reported that its ID NOWâ„¢ molecular point-of-care test to detect novel coronavirus will be available starting this week with plans to quickly ramp up production to deliver 50,000 tests per day. More >

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus
Source: Streetwise Reports  (3/26/20)
Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. More >

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal
Source: Streetwise Reports  (3/25/20)
Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. More >

Blockchain Holdings Acquires COVID-19 Quarantine Tracker Already in Use in Hong Kong
Source: Streetwise Reports  (3/21/20)
The company anticipates adoption of the TRACEsafe system by other countries soon. More >

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment
Source: Streetwise Reports  (3/20/20)
Shares of Bellerophon Therapeutics reached a new 52-week high price after the firm reported that the FDA granted emergency expanded access for its INOpulse® nitric oxide delivery system device for use in treatment of COVID-19 virus. More >

OPKO Health Partners with NY State Health Dept. to Create COVID-19 Drive-Thru Testing Facility
Source: Streetwise Reports  (3/13/20)
OPKO Health shares traded more than 30% higher after the company reported its subsidiary BioReference Laboratories has formed a partnership with the N.Y. State Department of Health to provide COVID-19 testing for the first public drive-through testing facility on the East Coast. More >

Predictive Oncology Launches AI Vaccine and Drug Platform & Acquires Technology
Source: Streetwise Reports  (3/12/20)
Shares of Predictive Oncology traded higher after the company reported that it launched a new AI vaccine and drug development platform targeting coronaviruses and acute respiratory syndromes and that it is acquiring Soluble Therapeutics assets including its HSC Technology. More >

Surgical Imaging Firm Reports Positive Physician Response to Bladder Cancer Visualization System
Source: Streetwise Reports  (3/11/20)
Imagin Medical announced on-going research feedback on its i/Blueâ„¢ Imaging System which allows simultaneous viewing of white and blue light images during bladder cancer resection procedures. More >

Vir Biotech Shares Rise on Joint Research Efforts with the NIH to Combat Coronaviruses
Source: Streetwise Reports  (3/11/20)
Vir Biotechnology shares traded higher after the company reported that it has entered into a research collaboration with the National Institutes of Health Vaccine Research Center on antibodies against coronaviruses including SARS-CoV-2. More >

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test
Source: Streetwise Reports  (3/10/20)
Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. More >

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing
Source: Streetwise Reports  (3/6/20)
Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. More >

GenMark Shares Trade 30% Higher on Yearly Earnings and Increased SARS-CoV-2 Virus Detection Test Kit Shipments
Source: Streetwise Reports  (3/3/20)
Shares of GenMark Diagnostics traded higher after the firm reported FY/19 financial results and announced that it has increased global shipment of its test kits designed to detect the SARS-CoV-2 virus. More >

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor
Source: Streetwise Reports  (2/26/20)
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. More >

Tech Firm Announces New Deals Worth $1 Million
Source: Streetwise Reports  (2/21/20)
These newly signed contracts of HealthSpace Data Systems are with governmental agencies in two U.S. states. More >

The 'Virus' Technology That Kills Coronavirus Plus Lots of Other Pathogens
Source: Fincom Investment Partners for Streetwise Reports  (2/18/20)
Fincom Investment Partners profiles TOMI Environmental Solutions, whose SteraMist disinfectant technology kills the coronavirus. More >

Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change
Source: Streetwise Reports  (2/7/20)
Shares of Myriad Genetics traded 30% lower after the firm released Q2/20 earnings and announced the appointment of a new interim CEO. More >

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance
Source: Streetwise Reports  (1/29/20)
Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. More >

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test
Source: Streetwise Reports  (1/23/20)
Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimerâ„¢ platform. More >

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection
Source: Chris Temple for Streetwise Reports  (1/14/20)
Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. More >

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery
Source: Streetwise Reports  (1/14/20)
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' More >

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery
Source: Streetwise Reports  (1/14/20)
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. More >

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications
Source: Streetwise Reports  (1/13/20)
Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in four different solid tumor indications. More >

Developer Completes Design Verification of Imaging Device for Bladder Cancer
Source: Streetwise Reports  (1/10/20)
In doing so, it gets one step closer to market approval from U.S. regulators. More >